First National Bank of Omaha’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-293
| Closed | -$308K | – | 312 |
|
|
2024
Q2 | $308K | Buy |
+293
| New | +$308K | 0.02% | 280 |
|
|
2024
Q1 | – | Sell |
-431
| Closed | -$379K | – | 339 |
|
|
2023
Q4 | $379K | Sell |
431
-95
| -18% | -$83.4K | 0.02% | 282 |
|
|
2023
Q3 | $433K | Sell |
526
-591
| -53% | -$486K | 0.03% | 272 |
|
|
2023
Q2 | $803K | Sell |
1,117
-4,389
| -80% | -$3.15M | 0.05% | 231 |
|
|
2023
Q1 | $4.52M | Sell |
5,506
-254
| -4% | -$209K | 0.27% | 120 |
|
|
2022
Q4 | $4.16M | Sell |
5,760
-1,393
| -19% | -$1.01M | 0.26% | 124 |
|
|
2022
Q3 | $4.93M | Sell |
7,153
-302
| -4% | -$208K | 0.32% | 103 |
|
|
2022
Q2 | $4.41M | Sell |
7,455
-340
| -4% | -$201K | 0.27% | 117 |
|
|
2022
Q1 | $5.44M | Sell |
7,795
-13
| -0.2% | -$9.08K | 0.28% | 113 |
|
|
2021
Q4 | $4.93M | Sell |
7,808
-126
| -2% | -$79.6K | 0.24% | 133 |
|
|
2021
Q3 | $4.8M | Sell |
7,934
-1,926
| -20% | -$1.17M | 0.24% | 130 |
|
|
2021
Q2 | $4.67M | Hold |
9,860
| – | – | 0.24% | 133 |
|
|
2021
Q1 | $4.67M | Buy |
9,860
+1,365
| +16% | +$646K | 0.24% | 133 |
|
|
2020
Q4 | $4.1M | Buy |
8,495
+160
| +2% | +$77.3K | 0.22% | 137 |
|
|
2020
Q3 | $4.67M | Sell |
8,335
-171
| -2% | -$95.7K | 0.29% | 110 |
|
|
2020
Q2 | $5.31M | Sell |
8,506
-1,300
| -13% | -$811K | 0.36% | 92 |
|
|
2020
Q1 | $4.79M | Sell |
9,806
-1,694
| -15% | -$827K | 0.37% | 87 |
|
|
2019
Q4 | $4.32M | Buy |
+11,500
| New | +$4.32M | 0.26% | 128 |
|